Brigham and Women’s Hospital ushered in a new era of diagnostic and investigative capability in May 2017 when it installed the ultra-high field 7.0 Tesla (7.0T) magnetic resonance imaging (MRI) scanner in its Hale Building for Transformative Medicine. The first 7.0T to be installed in a clinical setting in North America, the powerful new technology is more than double the strength of current state-of-the-art MRI scanners, producing high-resolution images that provide unprecedented views into the structures and pathways of the human body. Following government approvals for use in clinical settings, the 7.0T will offer new insights into the underlying mechanisms of neurologic and musculoskeletal diseases.
“A true game changer, this new technology will help pave the way toward a new era in diagnosis, monitoring, and treatment for neurologic diseases.” —Srinivasan Mukundan Jr., MD, PhD
“Images from the new scanner will provide greater specificity for earlier diagnoses and more precise treatments, particularly for patients with neurodegenerative diseases like multiple sclerosis and epilepsy, and musculoskeletal conditions,” says Srinivasan Mukundan Jr., MD, PhD, medical director of Magnetic Resonance Imaging at BWH. “These images will help clinicians differentiate among diseases and provide stronger evidence for choosing the best treatment.”
This article was originally featured in the 2017 Honor Roll, which celebrates donors to Brigham and Women’s Hospital and Brigham and Women’s Faulkner Hospital. Check out more profiles of patients, clinicians, and researchers that illustrate the power of transformative philanthropy at the Brigham.